# BZW2

## Overview
BZW2, or basic leucine zipper and W2 domains 2, is a gene that encodes a protein involved in the regulation of translation and is implicated in various oncogenic processes. The BZW2 protein is categorized as a member of the basic-region leucine zipper (bZIP) superfamily, which is known for its role in transcriptional regulation. It contains a bZIP domain essential for DNA binding and dimerization, as well as W2 domains that facilitate protein-protein interactions, contributing to its function in translation regulation and tumorigenesis (Liu2020&lt; Li2021BZW25MP1; miRlet7a5p; p&gt). BZW2 is involved in the modulation of the non-AUG initiation rate, influencing the translation of specific transcription factors such as ATF4, and plays a significant role in the PI3K/AKT/mTOR signaling pathway, which is crucial in cancer development (Liu2020&lt; Li2021BZW25MP1; miRlet7a5p; p&gt). The protein's interactions with various eukaryotic translation initiation factors and its involvement in oncogenic pathways underscore its potential as a therapeutic target in cancer treatment (Jin2024BZW2; Li2021BZW25MP1).

## Structure
The BZW2 protein, also known as 5MP1, is involved in translation regulation and is implicated in tumorigenesis across several cancers. It is a 419 amino acid protein that features a basic leucine zipper (bZIP) domain, which is crucial for DNA binding and dimerization, and W2 domains that facilitate protein-protein interactions (Liu2020&lt; Li2021BZW25MP1; miRlet7a5p; p&gt). The bZIP domain is part of the bZIP superfamily of transcription factors, which are known for their roles in transcriptional regulation (Chiou2019Overexpression).

BZW2 is associated with the regulation of the PI3K/AKT/mTOR signaling pathway, which is significant in cancer development (Liu2020&lt; miRlet7a5p; p&gt). It interacts with eukaryotic translation initiation factors and is involved in maintaining the homeostasis of the non-AUG translatome, indicating its role in translation regulation (Li2021BZW25MP1). The protein is also linked to the translation of transcription factors like ATF4 and the reprogramming of c-Myc translation, highlighting its involvement in oncogenic processes (Li2021BZW25MP1).

Post-translational modifications, such as phosphorylation, may affect BZW2's function and interactions, although specific details on these modifications are not provided in the context (Li2021BZW25MP1).

## Function
The BZW2 gene encodes a protein that is part of the basic-region leucine zipper (bZIP) superfamily and functions as a translation regulatory protein. In healthy human cells, BZW2 is involved in the regulation of protein synthesis by modulating the non-AUG initiation rate, a critical step in linking mRNA to proteins. This regulation is essential for controlling the translation of specific transcription factors, such as ATF4, which enhances cell survival under stress conditions (Li2021BZW25MP1).

BZW2 acts as a competitor or mimic of the eukaryotic translation initiation factor 5 (eIF5), which is involved in the initiation of translation through its GTPase activation protein (GAP) function. BZW2's interaction with eIF5 is crucial for maintaining the homeostasis of the non-AUG translatome, ensuring coordinated expression with eIF5 (Li2021BZW25MP1).

In terms of cellular localization, BZW2 is active in the cytoplasm, where it influences the assembly of ribosomal subunits and mRNA translation. This activity plays a significant role in cell growth and proliferation by modulating protein production, thereby contributing to the fine-tuning of protein synthesis and cellular stress responses in healthy cells (Li2021BZW25MP1).

## Clinical Significance
The BZW2 gene has been implicated in the progression of several cancers due to its altered expression levels. In pancreatic adenocarcinoma (PAAD), BZW2 is upregulated in cancerous tissues compared to normal tissues, and higher expression levels are associated with poorer overall survival. It is considered an independent predictor of poor prognosis in PAAD patients (Ge2022Expression). In lung adenocarcinoma (LUAD), BZW2 is also overexpressed and linked to poor prognosis. It promotes tumor growth and metastasis by enhancing the ubiquitination and degradation of GSK3β, thereby activating the Wnt/β-catenin signaling pathway (Jin2024BZW2).

In hepatocellular carcinoma (HCC), BZW2 is significantly upregulated and associated with cancer progression. Its overexpression enhances cell proliferation and invasion, while its knockdown reduces these effects and increases apoptosis. BZW2 influences the PI3K/AKT/mTOR signaling pathway and modulates c-Myc expression, contributing to HCC pathogenesis (Jin2019Role; Li2021BZW25MP1). In muscle-invasive bladder cancer (MIBC), BZW2 expression is higher in tumor tissues, and its knockdown results in inhibited cell growth and induced apoptosis, suggesting its oncogenic role (Gao2019BZW2). These findings highlight BZW2 as a potential biomarker and therapeutic target in various cancers.

## Interactions
BZW2 is involved in various protein interactions that influence its role in cellular processes. In pancreatic adenocarcinoma, BZW2 interacts with proteins such as AGR3, eIF1, eIF2S2, eIF5, and SNX13, which are also associated with BZW1, indicating a shared interaction network (Ge2022Expression). In lung adenocarcinoma, BZW2 interacts with glycogen synthase kinase-3 beta (GSK3β) in the cytoplasm, promoting its ubiquitination and degradation. This interaction activates the Wnt/β-catenin signaling pathway, contributing to cancer progression (Jin2024BZW2).

In hepatocellular carcinoma, BZW2 interacts with eIF5, a member of the eIF family, and is linked to the regulation of the oncoprotein c-Myc. BZW2 upregulation increases c-Myc expression, while its depletion reduces c-Myc levels, affecting cell cycle progression (Li2021BZW25MP1). BZW2 is also involved in the nuclear import process in acute myeloid leukemia, interacting with importin 11 (IPO11) and playing a role in maintaining the properties of leukemia stem cells (Nachmias2022IPO11). These interactions highlight BZW2's involvement in critical signaling pathways and its potential as a therapeutic target in various cancers.


## References


[1. (Gao2019BZW2) Haifeng Gao, Guanghai Yu, Xian Zhang, Song Yu, Yu Sun, and Yinghua Li. Bzw2 gene knockdown induces cell growth inhibition, g1 arrest and apoptosis in muscle‐invasive bladder cancers: a microarray pathway analysis. Journal of Cellular and Molecular Medicine, 23(6):3905–3915, April 2019. URL: http://dx.doi.org/10.1111/jcmm.14266, doi:10.1111/jcmm.14266. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.14266)

[2. (Nachmias2022IPO11) Boaz Nachmias, Dilshad H. Khan, Veronique Voisin, Arvind S. Mer, Geethu Emily Thomas, Nadav Segev, Jonathan St-Germain, Rose Hurren, Marcela Gronda, Aaron Botham, Xiaoming Wang, Neil Maclean, Ayesh K. Seneviratne, Nathan Duong, Changjiang Xu, Andrea Arruda, Elias Orouji, Arash Algouneh, Razqallah Hakem, Liran Shlush, Mark D. Minden, Brian Raught, Gary D. Bader, and Aaron D. Schimmer. Ipo11 regulates the nuclear import of bzw1/2 and is necessary for aml cells and stem cells. Leukemia, 36(5):1283–1295, February 2022. URL: http://dx.doi.org/10.1038/s41375-022-01513-4, doi:10.1038/s41375-022-01513-4. This article has 8 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41375-022-01513-4)

[3. (Jin2019Role) Xin Jin, Mingmei Liao, Lihua Zhang, Manyi Yang, and Jinfeng Zhao. Role of the novel gene bzw2 in the development of hepatocellular carcinoma. Journal of Cellular Physiology, 234(9):16592–16600, February 2019. URL: http://dx.doi.org/10.1002/jcp.28331, doi:10.1002/jcp.28331. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.28331)

[4. (Chiou2019Overexpression) Jean Chiou, Yu-Chan Chang, Yi-Hua Jan, Hsing-Fang Tsai, Chih-Jen Yang, Ming-Shyan Huang, Yung-Luen Yu, and Michael Hsiao. Overexpression of bzw1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis. Scientific Reports, October 2019. URL: http://dx.doi.org/10.1038/s41598-019-50874-x, doi:10.1038/s41598-019-50874-x. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-50874-x)

[5. (Ge2022Expression) Jiachen Ge, Senmao Mu, Erwei Xiao, Guangjin Tian, Lianyuan Tao, and Deyu Li. Expression, oncological and immunological characterizations of bzw1/2 in pancreatic adenocarcinoma. Frontiers in Genetics, October 2022. URL: http://dx.doi.org/10.3389/fgene.2022.1002673, doi:10.3389/fgene.2022.1002673. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1002673)

[6. (Li2021BZW25MP1) Guoxiong Li, Anqian Lu, Anna Chen, Shuang Geng, Yu Xu, Xin Chen, and Jin Yang. Bzw2/5mp1 acts as a promising target in hepatocellular carcinoma. Journal of Cancer, 12(17):5125–5135, 2021. URL: http://dx.doi.org/10.7150/jca.53282, doi:10.7150/jca.53282. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.53282)

[7. (Jin2024BZW2) Kai Jin, Yongmeng Li, Ruyuan Wei, Yanfei Liu, Shuai Wang, and Hui Tian. Bzw2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of gsk3β. Cell Death Discovery, February 2024. URL: http://dx.doi.org/10.1038/s41420-024-01879-7, doi:10.1038/s41420-024-01879-7. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-024-01879-7)